Microsoft Word[removed]DOCX

First Page		Document Content
Date: 2013-12-22 22:51:54 Von Willebrand disease Law Von Willebrand factor Declaratory judgment United States Patent and Trademark Office Term of patent Prior art Ristocetin induced platelet agglutination Patent law Blood Civil law		Microsoft Word[removed]DOCX Add to Reading List Source URL: patentdocs.typepad.com Download Document from Source Website File Size: 162,35 KB Share Document on Facebook

	Supplementary Materials Supplementary Figure 1. Ternary von Willebrand Factor A1-glycoprotein Ibalpha-botrocetin complex (PDB code: 1U0N) as an example of a non-interacting protein pair. Red – Von Willebrand factor (1 DocID: 1u0VZ - View Document
	Article pH-Dependent Interactions in Dimers Govern the Mechanics and Structure of von Willebrand Factor Jochen P. Mu¨ller,1,* Achim Lo¨f,1 Salome´ Mielke,1 Tobias Obser,2 Linda K. Bruetzel,1 Willem Vanderlinden,1,3 J DocID: 1qQnG - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1qHpD - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1q38M - View Document
	IP Internship project 7: Detailed characterisation of the molecular interaction between complement factor H (FH) and von Willebrand factor (VWF) Description Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic DocID: 1pS8s - View Document